Wolverine Trading, LLC Acelrx Pharmaceuticals Inc Transaction History

Wolverine Trading, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$1.03 - $1.69 $11,415 - $18,730	-11,083 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$0.76 - $2.07 $8,423 - $22,941	11,083 New	11,083 $14,000
Q4 2018 Feb 14, 2019	SELL	$2.13 - $4.8 $77,549 - $174,758	-36,408 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$2.6 - $4.6 $94,660 - $167,476	36,408 New	36,408 $140,000
Q1 2018 May 15, 2018	SELL	$1.7 - $2.35 $31,596 - $43,677	-18,586 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$1.75 - $5.5 $71,821 - $225,725	-41,041 Reduced 68.83%	18,586 $38,000
Q3 2017 Nov 15, 2017	BUY	$2.9 - $4.6 $172,918 - $274,284	59,627	59,627 $274,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.